US FDA Approves ARAKODA (tafenoquine) tablets for oral use, first preventative antimalarial approved in almost two decades

21st August, 2018

                               CONTACT US

For help or more information,  please don't hesitate to contacts us:

Registered Australian Office:

Biocelect Pty Ltd

Level 4, 51 Rawson Street, Epping NSW 2121, Australia

Registered New Zealand Office:

Biocelect New Zealand Limited

Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

General Inquiries: 1300 907 411 

To report a suspected side effect by a Biocelect
Pharmaceutical Drug or Vaccine: 1300 848 628

  • LinkedIn Social Icon
Biocelect Logo_Colour.png
  • LinkedIn Social Icon

Copyright 2019 Biocelect 

Level 4, 51 Rawson Street Epping, NSW Australia 2121